Vanda Pharmaceuticals (NASDAQ: VNDA) is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders to address unmet needs.
The company has assembled an experienced team along with a portfolio of clinical and commercial stage programs with the goal of bringing important new treatment options to patients.
Current Team (5)Update
2200 Pennsylvania Ave NW
Washington, DC 20037
- 04/12/06 -nasdaq.com